Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | SCN1A | P35498 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17509984 | 0.98 | TRPA1 (0.48) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| SCHEMBL8231406 | 0.79 | TRPA1 (0.47) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| SCHEMBL6137883 | 0.77 | TAAR1 (0.54) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| SCHEMBL7187362 | 0.77 | SLC6A2 (0.54) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| SCHEMBL7964365 | 0.77 | SLC6A2 (0.58) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| SCHEMBL21353 | 0.77 | SLC6A2 (0.58) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| SCHEMBL809278 | 0.77 | SLC6A2 (0.58) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| SCHEMBL28366193 | 0.75 | SLC6A2 (0.56) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| SCHEMBL28366661 | 0.75 | SLC6A2 (0.56) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 | |
| Bromide SCHEMBL28597373 | 0.75 | SLC6A2 (0.56) | TAAR1TRPA1SLC6A2CYP2C19CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7129378-B2 | Method of preparing amine stereoisomers | APSINTERM, LLC (US) | 2006-10-31 | — | — | US | claimed |
| US-20050165240-A1 | Method of preparing amine stereoisomers | APSINTERM, LLC | 2005-07-28 | — | — | US | claimed |
| EP-2546679-A1 | \"Three-dimensional dosimeter for penetrating radiation and method of use\ | Heuris Pharma LLC (US) | 2013-01-16 | — | — | EP | disclosed |
| US-7098463-B2 | Three-dimensional dosimeter for penetrating radiation and method of use | HEURIS PHARMA, LLC (US) | 2006-08-29 | — | — | US | disclosed |
| EP-1599743-A2 | THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE | Heuris Pharma LLC (US) | 2005-11-30 | — | — | EP | disclosed |
| US-20040211917-A1 | Three-dimensional dosimeter for penetrating radiation and method of use | HEURIS PHARMA, LLC | 2004-10-28 | — | — | US | disclosed |
| WO-2004079393-A2 | THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE | HEURIS PHARMA LLC (US) | 2004-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050165240-A1 | Method of preparing amine stereoisomers | SRM, TST, SMOX | TAAR1 93/4885TRPA1 4480/4885SLC6A2 387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.